Articles tagged with Cancer Patients
Researchers found that an intervention called IMPACT improved depression symptoms, quality of life, and functional impairment in older cancer patients. After six months, 55% of IMPACT participants showed a 50% or greater reduction in depression symptoms.
Researchers have developed a highly sensitive PSA assay using nanotechnology, enabling early detection of prostate cancer recurrence and improving treatment outcomes. The new technology has the potential to redefine the PSA 'zero' level, allowing for earlier diagnosis and targeted therapies.
A study found increasing age, male gender, open-ended catheter, and hematogenous malignancy as significant risk factors for TIVAD failure. Close-ended catheters had lower thrombosis rates, while solid malignancies had lower infection rates compared to hematogenous malignancies.
Research reveals that up to a quarter of testicular cancer survivors experience long-term neurological, hearing, and circulation problems, as well as a higher risk of secondary cancers. However, many survivors can successfully father children after treatment, with up to 80% successful pregnancies.
The American Society for Radiation Oncology (ASTRO) is partnering with Gilda's Club Chicago to promote cancer survivorship. The two organizations will participate in the Survivor Circle exhibit at ASTRO's 51st Annual Meeting, highlighting programs that help patients and families cope with cancer.
Halos of Hope, a non-profit organization established in 2007, will partner with ASTRO to provide comfort and dignity to chemo patients. The partnership aims to educate members about the organization's mission and programs focused on supporting cancer survivors.
A study of nearly 2,000 women with breast cancer found that 75.4% received breast-conserving surgery as initial therapy, while 23% underwent mastectomy. The results suggest that most surgeons recommend local therapy options and that patient preferences play a role in shaping treatment choices.
Researchers are studying naturally occurring cancers in dogs to inform the development of new cancer drugs, devices, and imaging strategies for human cancer patients. The study aims to improve care for human patients by leveraging insights gained from canine cancer biology.
Researchers found that a multivariable prediction model can accurately identify patients at low risk of recurrence, allowing for reduced chemotherapy treatments without compromising patient outcomes. The study suggests personalized medicine approach could improve cancer treatment decisions.
A recent study published in Molecular Cell reveals that the KEAP1 tumor suppressor binds to and degrades the cancer-promoting protein IKKß, which is involved in several types of cancer. The research suggests that underexpression of KEAP1 is associated with poor survival rates among breast cancer patients.
A study of over 2,000 women with stage II and III breast cancer found that achieving pathological complete response after treatment was not related to race. Despite racial disparities in breast cancer incidence and mortality rates, Hispanic women had better outcomes than white women.
Researchers have found that a standard treatment protocol can improve survival rates nearly two-fold for pediatric patients with choroid plexus tumors. The study suggests that chemotherapy and radiation can be effective in reducing mortality rates, contradicting previous research on surgical resection.
A study published in The Lancet Oncology found that immunodeficiency increases the risk of multiple cancers in HIV patients. Lower CD4 counts were linked to higher risks of certain cancers, while antiretroviral therapy reduced this risk. Effective cancer screening programs are recommended for HIV-positive individuals.
A new study from Michigan Medicine links nasopharyngeal cancer to human papillomavirus (HPV), a rare type of head and neck cancer affecting less than 1 in 100,000 Americans. The researchers found that HPV-positive tumors are more responsive to chemotherapy or radiation, leading to improved survival rates.
The University of Alabama at Birmingham Comprehensive Cancer Center has won an $11.5 million grant from the National Cancer Institute to explore groundbreaking cervical cancer research, prevention, and treatment. The grant will focus on next-generation human papillomavirus (HPV) vaccines for cervical cancer prevention and test therapeu...
Researchers identified tumor-suppressing genes ESR1 and HIC1 that predict late-stage laryngeal cancer and shorter survival in patients. Genetic abnormalities can aid in refining cancer staging and length of survival, potentially improving treatment options.
Researchers found that a mutated FGFR4 protein is associated with advanced-stage rhabdomyosarcoma and poor survival rates. Targeting this protein may offer new treatment options for individuals with the disease.
Researchers found SRS alone reduces learning and memory problems in cancer patients with one to three brain metastases. SRS plus WBRT results in twice the risk of cognitive decline, but no survival benefit.
Researchers at Fred Hutchinson Cancer Center and local institutions receive $16 million in federal stimulus funding to conduct comparative-effectiveness research on cancer diagnostics, genetic tests, and breast imaging. The projects aim to determine the optimal choices for balancing benefits and harms.
Researchers at the University of Liverpool have discovered that a DNA test can identify individuals with a higher risk of developing head and neck cancer. Nearly two thirds of tonsil tumour samples showed evidence of the HPV-16 gene, which may trigger protein production that increases cancer development.
Women with metastatic colorectal cancer tend to live longer than men, with those under 45 years old experiencing the greatest survival advantage. However, this benefit disappears with age, suggesting that hormones may be contributing to better outcomes in younger patients.
A study published in Cancer Prevention Research found that isolated mice developed significantly larger mammary gland tumors compared to group-housed mice, suggesting a link between social environment and cancer growth. The researchers also identified potential molecular biomarkers for breast cancer prevention.
A new nomogram developed by Ronald DeMatteo and colleagues predicts a patient's risk of cancer recurrence after surgery to remove primary GIST. The tool uses tumour size, location, and mitotic index as established prognostic criteria.
Researchers at the University of Toronto have created a microchip that can detect the type and severity of cancer in just 30 minutes, revolutionizing molecular diagnostics. The device uses nanomaterials to sense biomarkers indicative of cancer, providing speed, sensitivity, and accuracy not available with current technology.
A recent study published in the World Journal of Gastroenterology investigated whether Helicobacter pylori eradication therapy prevents gastric cancer. The research team found that younger patients with successful eradication had significantly lower incidence rates, while no overall prevention was observed for all patients.
HIV-infected patients are at higher risk for certain non-AIDS-defining malignancies such as anal, lung, Hodgkin's, melanoma and liver cancer. Researchers found a 60% increase in the incidence of these cancers among HIV-positive patients compared to those without HIV.
A Phase I clinical study by M. D. Anderson Cancer Center shows huachansu, a Chinese medicine derived from toad venom, has low toxicities even at doses eight times higher than conventional ones. The treatment slowed disease progression in some patients with liver, lung, colon and pancreatic cancer.
A phase I extension study has shown that 64% of patients with the BRAF mutation experienced partial response to a new compound, with rapid and dramatic shrinking of metastatic tumours. The treatment has fewer side effects compared to standard chemotherapy and is being explored as part of larger trials.
Researchers have identified two ultrasound patterns that can accurately identify cancer spread and tumor burden in melanoma patients. These patterns can predict overall survival and help doctors decide on the amount of surgery required.
Researchers have developed an assay to distinguish between harmful and harmless BRCA1 mutations, providing a way to identify women with increased breast cancer risk. This breakthrough has immense clinical potential for early prevention and treatment strategies.
Researchers found that whole-brain radiotherapy did not extend lives or improve independence in patients with limited brain metastases and stable cancer. However, it slowed cancer progression by five weeks and reduced the risk of brain-related deaths.
A new technique for reconstructing the palate after tonsil cancer surgery has been shown to maintain patients' ability to speak clearly and eat most foods. The technique, developed at Michigan Medicine, separates the mouth from the nasal cavity and closes during swallowing, allowing patients to recover their complex throat functions.
Researchers have developed two new blood tests that can aid in the early identification of patients with gastrointestinal (GI) cancers, making diagnosis simpler, cost-effective, and more acceptable to patients. The tests use DNA methylation to detect cancerous cells and show high sensitivity and specificity rates.
Researchers have discovered that space radiation can cause rapid bone loss in mice, which may lead to new treatments for cancer patients and astronauts. The study's findings suggest that existing medications like bisphosphonates could prevent this early loss of bone mass.
Researchers validated a simple blood test to assess treatment effectiveness in metastatic breast cancer patients, correlating CTC count with disease response. The study supports the use of CTC enumeration as an adjunct to standard clinical and radiographic methods.
Loyola will raise an additional $2 million from private donors to match The Coleman Foundation's $2 million grant. The new bone marrow transplant wing will be named The Coleman Foundation Bone Marrow Transplant Center.
A recent meta-analysis published in Cancer found that depression is associated with a higher risk of death in cancer patients, with death rates up to 25% higher for those experiencing depressive symptoms. The study highlights the need for systematic screening and treatment of psychological distress in cancer patients.
The first results of the European survey show that breakthrough cancer pain episodes are frequent, short-lived, and intensely painful, with 96% described as moderate to severe. The study suggests that fast-acting pain relief routes like intranasal opioids could be more effective for BTCP, improving patient compliance.
A head-to-head study confirms Instanyl's superiority over oral transmucosal fentanyl citrate (OTFC) in managing breakthrough cancer pain. Instanyl demonstrated significant pain relief at all time points, with patients preferring its ease of administration and faster onset of action.
A Phase I clinical trial tested GDC-0449, a Hedgehog Pathway Inhibitor, and demonstrated tumor shrinkage and limited side effects in patients with locally-advanced and metastatic basal cell carcinoma. The study's results suggest a durable clinical benefit, offering hope for patients with advanced skin cancer.
Researchers at Fox Chase Cancer Center found that long travel distances to high volume centers pose a barrier to optimal cancer care for some patients. The study showed that increased travel distances were more common among patients with less common cancers, such as esophageal and pancreatic cancer.
Researchers found that nadroparin almost halves the risk of developing blood clots in ambulatory cancer patients receiving chemotherapy. The study, published in The Lancet Oncology, showed a significant reduction in thromboembolic events in patients treated with nadroparin compared to those receiving placebo.
Researchers have identified a new group of genetic mutations involved in melanoma, with ERBB4 being the most frequently mutated PTK gene. The discovery could lead to specific therapies for melanoma patients with ERBB4 mutations.
Studies suggest that raising hemoglobin levels with erythropoietin can improve exercise tolerance in heart failure patients. However, a large-scale trial is needed to determine if higher Hb targets are associated with adverse cardiovascular events.
TRAF6 plays a key role in activating Akt, a signaling molecule associated with cancer growth. Ubiquitination of Akt is required for its activation and hyperactivation in mutant forms is linked to cancer development.
A recent study found that the racial disparity gap in prostate cancer stage at diagnosis has decreased over time. More men were diagnosed with prostate cancer at an earlier age and stage in 2004-2005 compared to earlier years, according to data from the Surveillance, Epidemiology, and End Results program.
Researchers identified LNγ2, LNβ3, and active MMP7 as molecular markers for tumor aggressiveness in biliary tract cancer. The study found that these markers were associated with tumor progression, depth of invasion, and advanced stage. Down-regulation of MMP7 expression resulted in a significant decrease in cancer cell invasion.
A study published in World Journal of Gastroenterology found that a large number of dissected lymph nodes in D2 dissection improves long-term survival and reduces recurrence rate for patients with node-negative gastric cancer. The number of resected lymph nodes is a key prognostic indicator, and increasing it leads to better survival o...
Researchers identified 50 microRNAs in saliva that could help detect oral cancer, including miR-125a and miR-200a. The findings suggest a major step forward in early oral cancer detection.
A new study found that unmarried cancer patients who are separated at diagnosis have poorer survival rates compared to widowed, divorced, and never married patients. The researchers suggest that the stress of separation may compromise an individual's immune system and lead to a greater susceptibility to cancer.
A new study from the University of Michigan Comprehensive Cancer Center found that hospitals treating more black cancer patients have lower survival rates for breast and colon cancer, regardless of race. The researchers suggest that factors such as hospital resources and quality of care are key contributors to these disparities.
A palliative care intervention improved quality of life and mood in patients with advanced cancer, but did not reduce symptom intensity or hospital stays. The study suggests that comprehensive cancer care should address physical, psychological, and social needs.
Researchers found a strong link between radiotherapy treatment and fatigue, with increases in serum markers of cytokine activity also associated. This study suggests that exposure to radiation releases inflammatory cytokines contributing to fatigue.
A palliative care intervention improved quality of life and mood in patients with advanced cancer, but had no significant impact on symptom intensity or hospital stays. The study found that patients receiving palliative care reported higher quality of life scores than those receiving usual care.
A new computer system has been successfully tested at Heidelberg University Hospital to improve pain therapy for cancer patients. The system, AiDPainCare, was found to have little variance from international guidelines and reduced patient pain.
A study found that cetuximab was not cost-effective for all patients with advanced colorectal cancer. However, it showed promise when used in patients whose tumors had wild-type KRAS genes. The authors suggest restricting cetuximab treatment to these patients to save costs.
Adding anesthetic lidocaine to radiocolloid injection improves patient comfort without compromising SLN identification, reducing pain and discomfort for patients with early breast cancer. The study concludes that this practice should be introduced as standard.
Researchers sequenced a second leukemia patient's genome, discovering genetic changes also found in gliomas and AML-linked mutations. The study highlights the potential of genome sequencing to unravel cancer's genetic basis, paving the way for more effective treatments.
Researchers found that intermittent calorie restriction provided greater protection from mammary tumor development, even with a lower degree of calorie restriction. The study suggests that altering hormone levels, such as insulin and IGF-1, may play a key role in cancer prevention.
A phase I clinical trial enrolled its first patient only two days after FDA clearance, accelerating development of new cancer drugs. The joint effort between M.D. Anderson and AstraZeneca demonstrates how to shrink the time it takes to bring new therapies to patients.